Articles & News Stories

bahan 1 calcifilaksis

Description
Bab 1 kalsifilaksis
Published
of 8
All materials on our website are shared by users. If you have any questions about copyright issues, please report us to resolve them. We are always happy to assist you.
Related Documents
Share
Transcript
  Search UpToDateView Outline ToolsCalciphylaxis (calcifc uremic arteriolopathy)Authors:Sagar U igwe!ar #D ##Sc$a%i & Tha'hani #D #Sec*on +'itors:Stanley ,ol'-ar. #D/ Darryl 0uarles #DDeputy +'itor:Al.ert 0 /am #D$+1+$+C+Sigwe!ar SU Tha'hani $ 2ran'en.urg V#3 Calciphylaxis3  +ngl 4 #e' 56789 ;8:7;6<31ine A =acharias 43 Calciphylaxis is usually non>ulcera*ng: ris! -actors outcome an' therapy3 ?i'ney &nt 56659 @7:557632ran'en.urg V# ?ramann $ $othe  et al3 Calcifc uraemic arteriolopathy (calciphylaxis): 'ata -rom a large na*onwi'e registry3 ephrol Dial Transplant 567;9 5:75@3#cCarthy 4T +l>Ahary $A atelt #T et al3 Sur%i%al $is! 1actors an' +Bect o- Treatment in 767 a*entsith Calciphylaxis3 #ayo Clin roc 567@9 7:78<3igwe!ar SU ol- # Sterns $ ix 4?3 Calciphylaxis -rom nonuremic causes: a systema*c re%iew3 Clin 4 Am Soc ephrol 56689 :773S+/E+  ,A22&A& , ST$+2+/ $3 Sensi*a*on to calciphylaxis .y en'ogenous parathyroi' hormone3 +n'ocrinology 7@59 ;7:FF<3Chen TE /ehman 4S ,i.son /+ et al3 istopathology o- Calciphylaxis: Cohort Stu'y ith Clinical Correla*ons3 Am 4 Dermatopathol 567;9 :;F34eong S Domingue A$3 Calciphylaxis: Contro%ersies in athogenesis Diagnosis an' Treatment3 Am 4 #e' Sci 567@9 F7:57;3Au S Craw-or' $&3 Three>'imensional analysis o- a calciphylaxis plaGue: clues to pathogenesis3 4 Am Aca'Dermatol 56659 <;:F3?ramann $ 2ran'en.urg V# Schurgers /4 et al3 o%el insights into osteogenesis an' matrix remo'elling associate' with calcifc uraemic arteriolopathy3 ephrol Dial Transplant 5679 58:8F@3igwe!ar SU 4iramong!olchai  un'erer 1 et al3 &ncrease' 2one #orphogene*c rotein Signaling in the Cutaneous Vasculature o- a*ents with Calciphylaxis3 Am 4 ephrol 567;9 <@:<53  Tian 1 aHerson AT Da%ic! 44 et al3 The cutaneous expression o- %itamin ?>'epen'ent an' other osteogenic proteins in calciphylaxis stra*fe' .y clinical -eatures an' war-arin use: A case control stu'y3 4 Am Aca' Dermatol 567@9 ;F:8<63#agro C# #omtahen S agen 43 Osteopon*n expression in .iopsies o- calciphylaxis3 +ur 4 Dermatol 567F9 5F:563Ahme' S OIeill ?D oo' A1 et al3 Calciphylaxis is associate' with hyperphosphatemia an' increase' osteopon*n expression .y %ascular smooth muscle cells3 Am 4 ?i'ney Dis 56679 ;:75@;3eenig $3 athogenesis o- calciphylaxis: ans Selye to nuclear -actor !appa>23 4 Am Aca' Dermatol 56689 F8:<F83Chen J OIeill ? A!l ? #oe S#3 A'ipocyte in'uce' arterial calcifca*on is pre%ente' with so'ium thiosul-ate3 2iochem 2iophys $es Commun 567<9 <<:7F73Selye  Somogyi A #Kcs &3 Calcergy inhi.ite' .y calciphylac*c challengers3 Science 7@89 7F:7@73Arch>1errer 4+ 2een!en S $ue / et al3 Therapy -or calciphylaxis: an outcome analysis3 Surgery 5669 7<:<73igwe!ar SU 2han & Turchin A et al3 Sta*n use an' calcifc uremic arteriolopathy: a matche' case>control stu'y3 Am 4 ephrol 5679 ;:5F31loege 4 ?u.o E 1loege A et al3 The +Bect o- Cinacalcet on Calcifc Uremic Arteriolopathy +%ents in a*ents $ecei%ing emo'ialysis: The +VO/V+ Trial3 Clin 4 Am Soc ephrol 567F9 76:8663+VO/V+ Trial &n%es*gators Chertow ,# 2loc! ,A et al3 +Bect o- cinacalcet on car'io%ascular 'isease in pa*ents un'ergoing 'ialysis3  +ngl 4 #e' 56759 @;:5<853igwe!ar SU =hao S enger 4 et al3 A a*onally $epresenta*%e Stu'y o- Calcifc Uremic Arteriolopathy$is! 1actors3 4 Am Soc ephrol 567@9 5;:<573?eHeler # 2iggar 3 +%ol%ing calciphylaxis>>what ran'omie' controlle' trials can contri.ute to the capture o- rare 'iseases3 Clin 4 Am Soc ephrol 567F9 76:;5@3rice A illiamson #? guyen T# Than T3 Serum le%els o- the -etuin>mineral complex correlate with artery calcifca*on in the rat3 4 2iol Chem 566<9 5;:7F<3rice A Omi'  Than T illiamson #?3 The amino .isphosphonate i.an'ronate pre%ents calciphylaxis in the rat at 'oses that inhi.it .one resorp*on3 Calci- Tissue &nt 56659 ;7:F@3$othe  2ran'en.urg V aun # et al3 +cto>FI >ucleo*'ase CD; (TF+) %itamin D receptor an' 1,15 gene polymorphisms may play a role in the 'e%elopment o- calcifc uremic arteriolopathy in 'ialysis pa*ents > Data -rom the ,erman Calciphylaxis $egistry3 /oS One 567;9 75:e67;5<6;3  eiss A DuChesne A Denec!e 2 et al3 Structural .asis o- calcifca*on inhi.i*on .y alpha 5>S glycoproteinL-etuin>A3 1orma*on o- colloi'al calciprotein par*cles3 4 2iol Chem 5669 5;8:73Scha-er C eiss A Schwar A et al3 The serum protein alpha 5>eremans>Schmi' glycoproteinL-etuin>A is a systemically ac*ng inhi.itor o- ectopic calcifca*on3 4 Clin &n%est 5669 775:F;3Coolino # ,alassi A 2ion'i #/ et al3 Serum -etuin>A le%els lin! inMamma*on an' car'io%ascular calcifca*on in hemo'ialysis pa*ents3 Am 4 ephrol 566@9 5@:<53?eHeler # 2ongart  esten-el' $ et al3 Associa*on o- low -etuin>A (AS,) concentra*ons in serum with car'io%ascular mortality in pa*ents on 'ialysis: a cross>sec*onal stu'y3 /ancet 5669 @7:85;3/e.reton 4 4oisel 1 $aoult 4 et al3 Serum concentra*on o- human alpha 5 S glycoprotein 'uring the inMammatory process: e%i'ence that alpha 5 S glycoprotein is a nega*%e acute>phase reactant3 4 Clin &n%est 7;9 @<:77783allin $ Cain D Sane DC3 #atrix ,la protein synthesis an' gamma>car.oxyla*on in the aor*c %essel wallan' proli-era*ng %ascular smooth muscle cells>>a cell system which resem.les the system in .one cells3 Throm. aemost 79 85:7;@<3/uo , Ducy  #c?ee #D et al3 Spontaneous calcifca*on o- arteries an' car*lage in mice lac!ing matrix ,/A protein3 ature 7;9 8@:;83ayashi # Ta!amatsu & ?anno E et al3 A case>control stu'y o- calciphylaxis in 4apanese en'>stage renal 'isease pa*ents3 ephrol Dial Transplant 56759 5;:7F863Coates T ?ir!lan' ,S Dymoc! $2 et al3 Cutaneous necrosis -rom calcifc uremic arteriolopathy3 Am 4 ?i'ney Dis 789 5:8<3#ar!ello TC a! /? St ilaire C et al3 Vascular pathology o- me'ial arterial calcifca*ons in TF+ 'efciency: implica*ons -or the role o- a'enosine in pseu'oxanthoma elas*cum3 #ol ,enet #eta. 5677976:<<3eenig $ Sewell /D Da%is #D et al3 Calciphylaxis: natural history ris! -actor analysis an' outcome3 4 Am Aca' Dermatol 566;9 F@:F@3igwe!ar SU ?roshins!y D aarian $# et al3 Calciphylaxis: ris! -actors 'iagnosis an' treatment3 Am 4 ?i'ney Dis 567F9 @@:73#an'el.rot DA Santos  2urt $? et al3 $esolu*on o- S/+>relate' soN>*ssue calcifca*on -ollowing haematopoie*c stem cell transplanta*on3 ephrol Dial Transplant 56689 5:5@;3Slough S Ser%illa ?S ar-or' A# et al3 Associa*on .etween calciphylaxis an' inMamma*on in two pa*ents on chronic 'ialysis3 A'% erit Dial 566@9 55:7;73igwe!ar SU Soli' CA An!ers + et al3 0uan*-ying a rare 'isease in a'ministra*%e 'ata: the example o- calciphylaxis3 4 ,en &ntern #e' 567<9 5 Suppl :S;5<3  Angelis # ong // #yers SA ong /#3 Calciphylaxis in pa*ents on hemo'ialysis: a pre%alence stu'y3 Surgery 7;9 755:7683#ahar A$ 4ohnson $4 ,illen D et al3 $is! -actors an' mortality associate' with calciphylaxis in en'>stage renal 'isease3 ?i'ney &nt 56679 @6:5<3,alloway A +l>Damanawi $ 2ar'sley V et al3 Vitamin ? antagonists pre'ispose to calciphylaxis in pa*ents with en'>stage renal 'isease3 ephron 567F9 75:7;3igwe!ar SU 2runelli S# #ea'e D et al3 So'ium thiosul-ate therapy -or calcifc uremic arteriolopathy3 Clin 4 Am Soc ephrol 5679 8:77@534anigan DT irsch D4 ?lassen ,A #acDonal' AS3 Calcife' su.cutaneous arterioles with in-arcts o- the su.cu*s an' s!in (calciphylaxis) in chronic renal -ailure3 Am 4 ?i'ney Dis 56669 F:F8832leyer A4 Choi # &gwemeie 2 et al3 A case control stu'y o- proximal calciphylaxis3 Am 4 ?i'ney Dis 789 5:;@3Do.ry AS ?o / St 4ohn 4 et al3 Associa*on 2etween ypercoagula.le Con'i*ons an' Calciphylaxis in a*ents ith $enal Disease: A Case>Control Stu'y3 4A#A Dermatol 56789 7F<:7853+l>Ahary $A atelt #T #c2ane $D et al3 Calciphylaxis: A Disease o- annicular Throm.osis3 #ayo Clin roc 567@9 7:7F3Amuluru / igh  iaH ?# et al3 #etal 'eposi*on in calcifc uremic arteriolopathy3 4 Am Aca' Dermatol 5669 @7:;31arah # Craw-or' $& /e%in A Chan Ean C3 Calciphylaxis in the current era: emerging IironicI -eaturesP ephrol Dial Transplant 56779 5@:7731ine A 1ontaine 23 Calciphylaxis: the .eginning o- the en'P erit Dial &nt 56689 58:5@83=hang E Corapi ?# /uongo # et al3 Calciphylaxis in peritoneal 'ialysis pa*ents: a single center cohort stu'y3 &nt 4 ephrol $eno%asc Dis 567@9 :5F3Eu E 2hutani T ?orni! $ et al3 ar-arin>Associate' onuremic Calciphylaxis3 4A#A Dermatol 567;9 7F:631ischer A #orris D43 athogenesis o- calciphylaxis: stu'y o- three cases with literature re%iew3 um athol 7F9 5@:76FF3a-ner 4 ?eusch , ahl C et al3 Uremic small>artery 'isease with me'ial calcifca*on an' in*mal hyperplasia (so>calle' calciphylaxis): a complica*on o- chronic renal -ailure an' .eneft -rom parathyroi'ectomy3 4 Am Aca' Dermatol 7F9 :F<3a-ner 4 ?eusch , ahl C 2urg ,3 Calciphylaxis: a syn'rome o- s!in necrosis an' acral gangrene in chronic renal -ailure3 Vasa 789 5;:7;3
We Need Your Support
Thank you for visiting our website and your interest in our free products and services. We are nonprofit website to share and download documents. To the running of this website, we need your help to support us.

Thanks to everyone for your continued support.

No, Thanks